Zydus Lifesciences Limited has released its financial results for the fourth quarter and the full fiscal year of 2024, showcasing impressive growth and operational success. The company’s revenue from operations reached Rs. 195,474 million for the year, marking a 13% increase from the previous year. The net profit saw a remarkable surge of 97%, totaling […]
Mankind Pharma India, the nation’s fourth-largest pharmaceutical company, announced robust financial results for the fourth quarter and the fiscal year ending March 31, 2024. Demonstrating substantial year-over-year growth, the company’s Profit After Tax (PAT) surged by 62% to Rs 477 crores in Q4 and 48% to Rs 1,942 crores for the fiscal year. Key Financial […]
In a significant development in the pharmaceutical industry, Suven Pharmaceuticals Limited (Suven) and Cohance Lifesciences Limited (Cohance) have announced a proposed scheme of amalgamation, marking a pivotal moment in the journey of both companies. The merger is set to enhance Suven’s standing in the Contract Development and Manufacturing Organization (CDMO) space, aiming for leadership by […]